SOURCE: InQpharm North America, LLC

November 24, 2016 06:00 ET

New cutting-edge weight management product coming to Canadian store shelves this Fall

THORNTON, ON and SALT LAKE CITY, UT--(Marketwired - November 24, 2016) - A new weight management product available in more than 25 countries, bmiSMART™ I-REMOVE™, is coming to Canada this Fall.

Available in oral tablet format, bmiSMART I-REMOVE consists of Litramine Fat Binder™, a naturally derived product which helps users achieve weight management goals while being gentle on the body. It targets the fat in the food that you eat and was developed through years of research on natural compounds. Litramine Fat Binder has been the top selling weight management product in Europe for the past five years, according to IMS health data.

Litramine Fat Binder is made from a proprietary blend of fibres consisting of prickly pear (Opuntia ficus-indica), acacia gum (Acacia sp.) and gamma cyclodextrin. These fibres interact synergistically to contribute to the two main functional properties of I-REMOVE: dietary fat binding and elimination; and promotes the feeling of satiety (of feeling full).

"Litramine Fat Binder binds fat into molecules too large to be absorbed, that are then secreted naturally. Reduced calories leads to weight loss," says Matthias Miller, Chief Scientific Officer, InQPharm Group.

Published in Obesity in 2013, studies indicate that Litramine significantly reduces the body weight of overweight and obese subjects, an average of 8.37 pounds (3.76 kilograms) up to 9.47 pounds (4.26 kilograms) after 12 weeks of use vs. the placebo group on a similar calorie reduced diet. A study published in Current Therapeutic Research in 2014 found that Litramine significantly increases fecal fat excretion with an average excretion of 15.79 per cent compared to the placebo average of 4.56 per cent. thus cutting up to 28.39 per cent of dietary fats. Another study, published in the Journal of Obesity in 2015 found that 92% of Litramine subjects were able to maintain their body weight after the initial weight loss vs. 25% in the placebo group.

Adult dosage is two tablets with at least one glass of liquid three times per day immediately after each meal. Allow two hours before other medications or natural health products. Maximum dosage is six tablets per day.

Available at health stores across the country as well as many Rexall pharmacies, bmiSMART I-REMOVE carries an MSRP of $99.99 for a 30 day supply of 180 tablets.

BmiSMART I-REMOVE is developed and manufactured by InQpharm, a global life sciences company that develops healthcare products rooted in nature and optimized through science. InQpharm delivers innovative solutions that nourish, protect, and improve lives in the consumer and animal health arenas. For more information, please visit www.bmismart.ca.

Contact Information